Through my own DD and IMO moving forward:
More incoming inquiries vs. outgoing inquiries for Actipatch
Big Pharma, now on the radar for potential interest. Purdue Fredrick (Oxycotin) company on the radar!
New and imminent partnerships pending..ANDA on steroids distributorship and sales force globally. Coming our way soon!
Overall company sentiment very positive. A great CSO officer who know's his stuff!
Back trial data is ready to go for FDA review via 510k submittal
Actipatch is being more than shelf spaced, but being positioned for brand quality, exposure and awareness. Do not take the CARE pharmacy PR lightly..this is truly a break through for pain management and pain education via the ongoing opiate epidemic shift. This will become many large scaled companies new alternative to address this exploited epidemic for overall epidemic value added service and face value reputation to this crisis.
Manufacturing status has a green light for influx of orders..No concern here with the company
Increasing awareness of Actipatch via multiple chains of Networking
SEC situation on hold and better forward optimism
Back pain trial data currently being packaged and historical learning will assist the company in a more expedient FDA process.
Currently, the incoming inquiries are numerous regarding Actipatch
The company is being proactively astute with opportunity
5,000 NHS data base to be leveraged globally. This is an extremely large data base for pain management.
Multiple products for multiple unmet disease states!
Menstrual and Migraine treatment studies to supplement commercial applications
A new massive distributorship coming your way soon!
